NEW INSIGHTS INTO THE PATHOGENESIS OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS

[1] Virchow R, Zur cellulose‐frage, Virchows Arch, 6, (1854)

[2] Cohen AS, Connors LH, The pathogenesis and biochemistry of amyloidosis, J Pathol, 151, pp. 1-10, (1987)

[3] Pepys MB, Amyloidosis: Some recent developments, Q J Med, 67, pp. 283-298, (1988)

[4] Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Et al., Hemodialyse, syndrome du canal carpien et substance amyloide, Nouv Press Med, 24, (1980)

[5] Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunimoto T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K, A new form of amyloid protein associated with chronic haemodialysis was identified as beta 2 microglobulin, Biochem Biophys Res Commun, 129, pp. 701-706, (1985)

[6] Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B, Beta 2 microglobulin is an amyloidogenic protein in man, J Clin Invest, 76, pp. 2425-2429, (1985)

[7] Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M, Beta 2 microglobulin, a new form of amyloid protein associated with chronic hemodialysis, Kidney Int, 30, pp. 385-390, (1986)

[8] Connors LH, Shirahama T, Skinner M, Fenves A, Cohen AS, In vitro formation of amyloid fibrils from intact beta 2 microglobulin, Biochem Biophys Res Commun, 131, pp. 1063-1068, (1985)

[9] Gejyo F, Homma N, Suzuki Y, Arakawa M, Serum levels of beta 2 microglobulin, as a new form of amyloid protein in patients undergoing long‐term hemodialysis, N Engl J Med, 314, pp. 585-586, (1986)

[10] Argiles A, Mourad G, Berta PH, Polito C, Canaud B, Robinet-Levy M, Mion C, Dialysis associated amyloidosis in a patient on long‐term post‐dilutional hemofiltration, Nephron, 46, pp. 96-97, (1987)

[1] Virchow R, Zur cellulose‐frage, Virchows Arch, 6, (1854)

[2] Cohen AS, Connors LH, The pathogenesis and biochemistry of amyloidosis, J Pathol, 151, pp. 1-10, (1987)

[3] Pepys MB, Amyloidosis: Some recent developments, Q J Med, 67, pp. 283-298, (1988)

[4] Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Et al., Hemodialyse, syndrome du canal carpien et substance amyloide, Nouv Press Med, 24, (1980)

[5] Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunimoto T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K, A new form of amyloid protein associated with chronic haemodialysis was identified as beta 2 microglobulin, Biochem Biophys Res Commun, 129, pp. 701-706, (1985)

[6] Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B, Beta 2 microglobulin is an amyloidogenic protein in man, J Clin Invest, 76, pp. 2425-2429, (1985)

[7] Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Maruyama Y, Hirasawa Y, Suzuki M, Arakawa M, Beta 2 microglobulin, a new form of amyloid protein associated with chronic hemodialysis, Kidney Int, 30, pp. 385-390, (1986)

[8] Connors LH, Shirahama T, Skinner M, Fenves A, Cohen AS, In vitro formation of amyloid fibrils from intact beta 2 microglobulin, Biochem Biophys Res Commun, 131, pp. 1063-1068, (1985)

[9] Gejyo F, Homma N, Suzuki Y, Arakawa M, Serum levels of beta 2 microglobulin, as a new form of amyloid protein in patients undergoing long‐term hemodialysis, N Engl J Med, 314, pp. 585-586, (1986)

[10] Argiles A, Mourad G, Berta PH, Polito C, Canaud B, Robinet-Levy M, Mion C, Dialysis associated amyloidosis in a patient on long‐term post‐dilutional hemofiltration, Nephron, 46, pp. 96-97, (1987)